Europe Api Intermediates Market
Taille du marché en milliards USD
TCAC :
% 
 Période de prévision |
2023 –2030 |
 Taille du marché (année de référence) |
USD 49,400.00 Million |
 Taille du marché (année de prévision) |
USD 79,332.30 Million |
 TCAC |
% |
| Principaux acteurs du marché |
>Europe API Intermediates Market, By Type (Veterinary Drug Intermediates Pharmaceutical / Bulk Drug Intermediates), Product (Bromo Compound, O-Benzyl Salbutamol, Hemisulfate, Oxirane, Bisoprolol Base, Chiral PCBHP, Pheniramine Base, Chlorpheniramine Base, Brompheniramine Base, Mepyramine/Pyrilamine Base, 6-Amino-1,3-Dimethyl Uracil, Theofylline, Acefylline, Xanthine, Nitriles, Others), Therapeutic Type (Autoimmune Diseases, Oncology, Metabolic Diseases, Ophthalmology, Cardiovascular Diseases, Infectious Diseases, Neurology, Respiratory Disorders, Dermatology, Urology, Others), Customers (Direct Users/Pharma Companies, Traders/Wholesalers/Distributors, Associations/Govt. Institutions/Pvt Institutions), End User (API Manufacturer, Finished Product Manufacturer), Distribution Channel (Direct Tender, Retail Sales, Others) - Industry Trends and Forecast to 2030.
Europe API Intermediates Market Analysis and Size
Pharmaceutical companies are actively involved in research and development (R&D) to create new drugs and improve existing formulations. This R&D effort requires a steady supply of high-quality API intermediates. Many pharmaceutical companies in Europe are outsourcing the production of API intermediates to third-party manufacturers, including those in other regions like Asia. This outsourcing allows European companies to reduce production costs and focus on drug development and marketing. The development of biosimilar, which are biological drugs that are highly similar to existing biologic products, has been on the rise in Europe. Producing biosimilar requires a reliable supply of API intermediates, contributing to market growth.
Data Bridge Market Research analyses that the Europe API intermediates market which was USD 49,400.00 million in 2022, is expected to reach USD 79,332.30 million by 2030, and is expected to undergo a CAGR of 6.1% during the forecast period 2023-2030. This indicates the market value. “Veterinary Drug Intermediates Pharmaceutical” dominates the type segment of the Europe API intermediates market owing to the increasing investment in healthcare. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Europe API Intermediates Market Scope and Segmentation
|
Report Metric |
Details |
|
Forecast Period |
2023 to 2030 |
|
Base Year |
2022 |
|
Historic Years |
2021 (Customizable to 2015-2020) |
|
Quantitative Units |
Revenue in USD Million, Volumes in Units, Pricing in USD |
|
Segments Covered |
Type (Veterinary Drug Intermediates Pharmaceutical / Bulk Drug Intermediates), Product (Bromo Compound, O-Benzyl Salbutamol, Hemisulfate, Oxirane, Bisoprolol Base, Chiral PCBHP, Pheniramine Base, Chlorpheniramine Base, Brompheniramine Base, Mepyramine/Pyrilamine Base, 6-Amino-1,3-Dimethyl Uracil, Theofylline, Acefylline, Xanthine, Nitriles, Others), Therapeutic Type (Autoimmune Diseases, Oncology, Metabolic Diseases, Ophthalmology, Cardiovascular Diseases, Infectious Diseases, Neurology, Respiratory Disorders, Dermatology, Urology, Others), Customers (Direct Users/Pharma Companies, Traders/Wholesalers/Distributors, Associations/Govt. Institutions/Pvt Institutions), End User (API Manufacturer, Finished Product Manufacturer), Distribution Channel (Direct Tender, Retail Sales, Others) |
|
Countries Covered |
Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, Rest of Europe |
|
Market Players Covered |
HIKAL Ltd.(India), Cambrex Corporation (U.S.), Ganesh-Group (India), AlzChem Group AG (Germany), Vasudha Pharma (India), Anyang General Chemical Co.,Ltd.(South Korea), Sarex (India), Sandoo Pharmaceuticals and Chemicals Co., Ltd.(China), Atul Ltd (India), Sandoz International GmbH (a subsidiary of Novartis AG) (Germany), Aceto (U.S.), Supriya Lifescience Ltd. (India), Vertellus (U.S.), Dishman Carbogen Amcis Ltd (India), Sanofi (France), Divi's Laboratories Limited (India), AARTI INDUSTRIES LIMITED (India), Aurobindo Pharma (India), BASF SE (Germany) |
|
Market Opportunities |
|
Market Definition
The active pharmaceutical ingredient (API) intermediates are the chemical compounds that are used as intermediate products in the synthesis or manufacturing of active pharmaceutical ingredients (APIs). API intermediates are essential components in the pharmaceutical manufacturing process, as they serve as building blocks for the creation of the final API. API intermediates are chemical compounds that are synthesized during the production of active pharmaceutical ingredients (APIs). They are intermediate stages in the chemical synthesis pathway, and they undergo further processing and modifications to ultimately become the API of a pharmaceutical product. API intermediates are crucial in the pharmaceutical industry, as they play a vital role in determining the quality, purity, and efficacy of the final drug product.
Europe API Intermediates Market Dynamics
Drivers
- Pharmaceutical Industry Growth
The pharmaceutical industry in Europe is characterized by a robust pipeline of new drug candidates and therapies. As pharmaceutical companies invest in research and development (R&D) to bring innovative drugs to market, they require a steady supply of high-quality API intermediates. Each new drug development project necessitates specific intermediates tailored to the drug's molecular structure. Pharmaceutical companies in Europe are engaged in the development of drugs across a wide range of therapeutic areas, including oncology, cardiovascular diseases, neurology, infectious diseases, and rare diseases. The diversity of therapeutic areas leads to a variety of API intermediate requirements, stimulating demand in the market.
- Rising Research and Development
Ongoing research and development efforts in the pharmaceutical sector lead to the creation of new drugs and therapies, requiring specific API intermediates. Pharmaceutical companies in Europe continually invest in R&D to discover and develop new drugs and therapies. The early stages of drug discovery and development often involve the synthesis and testing of numerous compounds, including API intermediates. As more drug candidates enter development pipelines, the demand for specialized intermediates increases. R&D efforts often focus on the development of customized drug formulations tailored to specific patient populations or therapeutic needs. This customization requires the synthesis of unique API intermediates that match the desired molecular structures and characteristics of the APIs.
Opportunity
- Rising Research Collaborations
Collaborations between pharmaceutical companies and research institutions in Europe often lead to the development of novel drugs and therapies. These research efforts may require the synthesis of specific API intermediates. The growth of the pharmaceutical industry in Europe is intricately linked to the demand for API intermediates. The development of new drugs, adherence to regulatory standards, customization needs, outsourcing practices, and expansion into emerging markets all contribute to the increasing demand for high-quality and reliable API intermediates in Europe.
Restraint/Challenge
- Regulatory Hurdles
The pharmaceutical industry, including the API intermediates sector, is subject to strict regulatory oversight in Europe. Compliance with Good Manufacturing Practices (GMP), Good Laboratory Practices (GLP), and other quality and safety standards is mandatory. Meeting these stringent requirements can be costly and time-consuming. Europe places a strong emphasis on environmental protection. API intermediate manufacturing processes often involve the use of chemicals and solvents. Compliance with environmental regulations, waste management, and sustainable practices can be challenging and expensive.
Recent Developments
- In January 2021, Vertellus has been acquired by the company, Pritzker Private Capital who partners with the middle-market companies established in North America and builds up the long-term relationship with that company. As Vertellus is considered as leading company or provider of specialty chemicals in different sectors such as healthcare, food & agriculture, personal care, transportation and coatings, so PPC has made a partnership with the company. This helped the company Vertellus to increase their market growth which will drive revenues of the company
- In November 2020, Cambrex Corporation had announced that the company will expand their API manufacturing capacity to meet the increasing demand from the consumer side. The company has invested USD 50.00 million to enhance their manufacturing capacity. The increase in API manufacturing will directly increase the production and requirement of intermediates which means that the company has to increase the manufacturing of both API and their intermediates. This expansion has helped the company to enhance their production in both the fields that is APIs and their intermediates which will increase the API intermediates market growth
Europe API Intermediates Market Scope
The Europe API intermediates market is segmented on the basis of type, product, therapeutic type, customers, end user, and distribution channel. The growth amongst these segments will help you analyse meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Veterinary Drug Intermediates Pharmaceutical
- Bulk Drug Intermediates
Product
- Bromo Compound
- O-Benzyl Salbutamol
- Hemisulfate, Oxirane
- Bisoprolol Base
- Chiral PCBHP
- Pheniramine Base
- Chlorpheniramine Base
- Brompheniramine Base
- Mepyramine/Pyrilamine Base
- 6-Amino-1,3-Dimethyl Uracil
- Theofylline
- Acefylline
- Xanthine
- Nitriles
- Others
Therapeutic Type
- Autoimmune Diseases
- Oncology
- Metabolic Diseases
- Ophthalmology
- Cardiovascular Diseases
- Infectious Diseases
- Neurology
- Respiratory Disorders
- Dermatology
- Urology
- Others
Customers
- Direct Users/Pharma Companies
- Traders/Wholesalers/Distributors
- Associations/Govt. Institutions/PVT Institutions
End User
- API Manufacturer
- Finished Product Manufacturer)
Distribution Channel
- Direct Tender
- Retail Sales
- Others
Europe API Intermediates Market Analysis/Insights
Europe API intermediates market is analyzed, and market size insights and trends are provided by type, product, therapeutic type, customers, end user, and distribution channel as referenced above.
The countries covered in the Europe API intermediates market report are Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, and Rest of Europe.
L'Allemagne domine le marché européen des intermédiaires API en termes de part de marché et de chiffre d'affaires et continuera de renforcer sa domination au cours de la période de prévision 2023-2030. Cela est dû à l'augmentation des dépenses de santé qui propulsera davantage le taux de croissance du marché dans cette région. En outre, des politiques de rémunération favorables dans le domaine de la santé, l'augmentation des plaies chroniques et une population vieillissante croissante propulseront davantage le taux de croissance du marché dans cette région.
La section pays du rapport fournit également des facteurs d'impact sur les marchés individuels et des changements dans la réglementation du marché qui ont un impact sur les tendances actuelles et futures du marché. Des points de données tels que l'analyse de la chaîne de valeur en aval et en amont, les tendances techniques et l'analyse des cinq forces du porteur, les études de cas sont quelques-uns des indicateurs utilisés pour prévoir le scénario de marché pour les différents pays. En outre, la présence et la disponibilité des marques européennes et les défis auxquels elles sont confrontées en raison de la concurrence importante ou rare des marques locales et nationales, l'impact des tarifs nationaux et des routes commerciales sont pris en compte tout en fournissant une analyse prévisionnelle des données nationales.
Croissance de la base installée des infrastructures de santé et pénétration des nouvelles technologies
Le marché européen des intermédiaires API vous fournit également une analyse détaillée du marché pour chaque pays, la croissance des dépenses de santé pour les équipements en capital, la base installée de différents types de produits pour le marché européen des intermédiaires API, l'impact de la technologie à l'aide de courbes de vie et les changements dans les scénarios réglementaires des soins de santé et leur impact sur le marché européen des intermédiaires API. Les données sont disponibles pour la période historique 2015-2020
Analyse du paysage concurrentiel et des parts de marché des intermédiaires API en Europe
Le paysage concurrentiel du marché européen des intermédiaires API fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence régionale, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit, la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises liées au marché européen des intermédiaires API.
Certains des principaux acteurs opérant sur le marché européen des intermédiaires API sont :
- HIKAL Ltd. (Inde)
- Cambrex Corporation (États-Unis)
- Groupe Ganesh (Inde)
- AlzChem Group AG (Allemagne)
- Vasudha Pharma (Inde)
- Anyang General Chemical Co., Ltd. (Corée du Sud)
- Sarex (Inde)
- Sandoo Pharmaceuticals and Chemicals Co., Ltd. (Chine)
- Atul Ltd (Inde)
- Sandoz International GmbH (Allemagne)
- Aceto (États-Unis)
- Supriya Lifescience Ltd. (Inde)
- Vertellus (États-Unis)
- Dishman Carbogen Amcis Ltd (Inde)
- Sanofi (France)
- Divi's Laboratories Limited (Inde)
- AARTI INDUSTRIES LIMITED (Inde)
- Aurobindo Pharma (Inde)
- BASF SE (Allemagne)
SKU-
Accédez en ligne au rapport sur le premier cloud mondial de veille économique
- Tableau de bord d'analyse de données interactif
- Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
- Accès d'analyste de recherche pour la personnalisation et les requêtes
- Analyse de la concurrence avec tableau de bord interactif
- Dernières actualités, mises à jour et analyse des tendances
- Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Table des matières
- introduction
- OBJECTIVES OF THE STUDY
- MARKET DEFINITION
- OVERVIEW of EUROPE API intermediates MARKET
- LIMITATIONs
- MARKETS COVERED
- MARKET SEGMENTATION
- MARKETS COVERED
- geographical scope
- years considered for the study
- currency and pricing
- DBMR TRIPOD DATA VALIDATION MODEL
- MULTIVARIATE MODELLING
- type LIFELINE CURVE
- primary interviews with key opinion leaders
- DBMR MARKET POSITION GRID
- vendor share analysis
- MARKET type COVERAGE GRID
- secondary sourcEs
- assumptions
- EXECUTIVE SUMMARY
- premium insight
- CURRENT SCENARIO OF IMPORT AND EXPORT OF API INTERMEDIATE
- Tentative Production and operational costs calculations which will ultimately lead to feasibility of the product manufacturing
- Tentative Land requirement for a Substantial Production Capacity Plant Set-Up
- EUROPE API INTERMEDIATES MARKET: 3C ANALYSIS-CHINA EFFECT
- THE U.S.-CHINA TRADE WAR
- INDO-CHINA GEOPOLITICAL ISSUES
- CHINESE SLOWDOWN DUE TO E&C OVER THE YEARS
- CHINESE SLOWDOWN DUE TO COVID-19 (CORONAVIRUS)
- Cost Analysis
- Analysis on China API intermediates:
- Conclusion:
- porters five forces model
- Pestel analysis
- Europe API INTERMEDIATES market: regulatORY
- THE U.S. REGULATORY GUIDANCE FOR NON-CLINICAL SAFETY EVALUATION OF API INTERMEDIATES
- CANADA REGULATORY GUIDANCE FOR API INTERMEDIATES
- EUROPE REGULATORY SCENARIO FOR API INTERMEDIATES
- JAPAN REGULATORY FOR API INTERMEDIATES
- MIDDLE EAST AND AFRICA REGULATORY FRAMEWORK FOR API INTERMEDIATES
- EUROPE API INTERMEDIATES MARKET: CONCLUSION
- TOP PRODUCTS AND THERAPEUTIC AREAS
- ADDITIONAL
- CUSTOMER SENTIMENTS/INCLINATION TOWARDS FINDING ALTERNATE VENDOR SOURCE
- LIST OF API OR FORMULATION COMPANIES WITH API INTERMEDIATE:
- Market Overview
- Drivers
- HIGH BURDEN OF CHRONIC DISEASES
- increase in aging population
- utilization of advanceD technology in active pharmaceutical ingredients (api) manufacturing
- increasing disease awareness and education
- research and development regarding pharmaceutical API and their intermediates
- restrainTs
- availability of sub-standard and counterfeit drugs
- product recalls
- high manufacturing cost
- stringent government regulations for api intermediates
- opportunities
- strategic initiatives by the market players
- increasing healthcare expenditure
- SOARING NUMBER OF API INTERMEDIATES MANUFACTURERS
- RISE IN NUMBER OF CONTRACT MANUFACTURING ORGANIZATIONS (CMO) AND CONTRACT RESEARCH ORGANIZATIONS (crO)
- challenges
- disruption in the supply chain of active pharmaceutical ingredients (api) during covid-19
- lack of workforce in pharma industries
- Impact of COVID 19 on Europe API Intermediates market
- IMPACT ON PRICE
- IMPACT ON DEMAND
- IMPACT ON SUPPLY CHAIIN
- STRATEGIC DECISIONS FOR MANUFACTURERS AFTER COVID-19 TO GAIN COMPETITIVE MARKET SHARE
- CONCLUSION
- Europe API intermediates MARKET, BY type
- overview
- pharmaceutical intermediates/ bulk drug intermediates
- Veterinary Drug Intermediates
- Europe API intermediates MARKET, BY product
- overview
- Nitriles
- bromo compound
- Chiral PCBHP
- Chlorpheniramine Base
- Brompheniramine Base
- Pheniramine Base
- O-Benzyl Salbutamol
- Bisoprolol Base
- Hemisulfate
- Oxirane
- Mepyramine/Pyrilamine Base
- Theofylline
- Acefylline
- Xanthine
- 6-Amino-1,3-Dimethyl Uracil
- others
- Europe API intermediates MARKET, BY therapeutic type
- overview
- Cardiovascular Diseases
- Metabolic Diseases
- infectious Diseases
- respiratory Diseases
- neurology
- oncology
- Autoimmune Disease
- Dermatology
- ophthalmology
- urology
- others
- Europe API intermediates MARKET, BY customers
- overview
- Direct Users/Pharma Companies
- Traders/Wholesalers/Distributors
- Associations/Govt. Institutions/Pvt Institutions
- Europe API intermediates MARKET, BY End User
- overview
- API manufacturer
- finished product manufacturer
- Europe API intermediates MARKET, BY distribution channel
- overview
- direct tender
- Retail Sale
- others
- Europe API Intermediates Market by geography
- EUROPE
- GERMANY
- U.K
- ITALY
- SPAIN
- FRANCE
- NETHERLANDS
- RUSSIA
- SWITZERLAND
- TURKEY
- AUSTRIA
- NORWAY
- HUNGARY
- LITHUANIA
- IRELAND
- POLAND
- REST OF ASIA PACIFIC
- Europe API Intermediates Market: COMPANY landscape
- company share analysis: Europe
- swot analysis
- company profile
- aurobindo pharma
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORFOLIO
- RECENT DEVELOPMENTS
- Divi’s laboratories limited
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- basf se
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- CAMBRIX CORPORATION
- COMPANY SNAPSHOT
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Sandoz International GmbH (a subsidiary of Novartis AG)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- aceto
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- hikal ltd.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- alzchem group ag
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- vertellus
- COMPANY SNAPSHOT
- PRODUCT CATEGORIES
- RECENT DEVELOPMENTS
- sanofi
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORFOLIO
- RECENT DEVELOPMENTS
- atul ltd
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- aarti industries limited
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- vasudha pharma
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- anyang general chemical co., Ltd.
- COMPANY SNAPSHOT
- PRODUCT PORFOLIO
- RECENT DEVELOPMENT
- dishman carbogen amics ltd
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORFOLIO
- RECENT DEVELOPMENTS
- ganesh-group
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- levachem company limited
- COMPANY SNAPSHOT
- PRODUCT PORFOLIO
- RECENT DEVELOPMENT
- sandoo pharmaceuticals and chemicals co., ltd.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- sarex
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- SUPRIYA LIFESCIENCE LTD.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- questionnaire
- related reports
Liste des tableaux
TABLE 1 EUROPE ACTIVE PHARMACEUTICAL INGREDIENTS INTERMEDIATES: CUSTOMIZATION (COUNTRIES INVOLVED IN IMPORT & EXPORT)
TABLE 2 Percentage Break up of Cost
TABLE 3 Tentative Land Requirement
TABLE 4 Percentage Break up of Plant Area
TABLE 5 Table: 1 EUROPE ACTIVE PHARMACEUTICAL INGREDIENTS INTERMEDIATES: LIST OF API OR FORMULATION COMPANIES WITH API INTERMEDIATE
TABLE 6 HEALTHCARE EXPENDITURE IN ASIA-PACIFIC
TABLE 7 MARKET PLAYERS OF API INTERMEDIATES
TABLE 8 Sales Data of API intermediates for 2019/2020
TABLE 9 Europe API intermediates Market, By Type, 2019-2028 (USD Million)
TABLE 10 Europe pharmaceutical intermediates/ bulk drug intermediates in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 11 Europe Veterinary Drug Intermediates in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 12 Europe API intermediates Market, By Product, 2019-2028 (USD Million)
TABLE 13 Europe nitriles in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 14 Europe bromo compound in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 15 Europe chiral PCBHP in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 16 Europe chlorpheniramine base in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 17 Europe brompheniramine base in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 18 Europe pheniramine base in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 19 Europe O-Benzyl Salbutamol in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 20 Europe bisoprolol base in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 21 Europe hemisulfate in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 22 Europe oxirane in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 23 Europe mepyramine/pyrilamine base in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 24 Europe theofylline in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 25 Europe acefylline in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 26 Europe Xanthine in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 27 Europe 6-amino-1, 3-dimethyl uracil in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 28 Europe others in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 29 Europe API intermediates Market, By THERAPEUTIC Type, 2019-2028 (USD Million)
TABLE 30 Europe cardiovascular diseases in API intermediates Market, By Region, 2017-2028 (USD Million)
TABLE 31 Europe metabolic diseases in API intermediates Market, By Region, 2019-2028 (USD Million)
TABLE 32 Europeinfectious diseases in API intermediates Market, By Region, 2019-2028 (USD Million)
TABLE 33 Europe respiratory diseases in API intermediates Market, By Region, 2019-2028 (USD Million)
TABLE 34 Europe neurology in API intermediates Market, By Region, 2019-2028 (USD Million)
TABLE 35 Europe oncology in API intermediates Market, By Region, 2019-2028 (USD Million)
TABLE 36 Europe autoimmune diseases in API intermediates Market, By Region, 2019-2028 (USD Million)
TABLE 37 Europe dermatology in API intermediates Market, By Region, 2019-2028 (USD Million)
TABLE 38 Europe ophthalmology in API intermediates Market, By Region, 2019-2028 (USD Million)
TABLE 39 Europe urology in API intermediates Market, By Region, 2019-2028 (USD Million)
TABLE 40 Europe others in API intermediates Market, By Region, 2019-2028 (USD Million)
TABLE 41 Europe API intermediates Market, By CUSTOMERS, 2019-2028 (USD Million)
TABLE 42 Europe Direct Users/Pharma Companies in API intermediates Market, By Region, 2019-2028 (USD Million)
TABLE 43 Europe Traders/Wholesalers/Distributors in API intermediates Market, By Region, 2019-2028 (USD Million)
TABLE 44 Europe Associations/Govt. Institutions/Pvt Institutionsin API intermediates Market, By Region, 2019-2028 (USD Million)
TABLE 45 Europe API intermediates Market, By END USER, 2019-2028 (USD Million)
TABLE 46 Europe API manufacturer in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 47 Europe finished product manufacturer in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 48 Europe API intermediates Market, By distribution channel, 2019-2028 (USD Million)
TABLE 49 Europe direct tender in API intermediates Market, By Region, 2019-2028 (USD Million)
TABLE 50 Europe retail sales in API intermediates Market, By Region, 2019-2028 (USD Million)
TABLE 51 Europe Othersin API intermediates Market, By Region, 2019-2028 (USD Million)
TABLE 52 Europe API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 53 Europe API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 54 Europe API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 55 Europe API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 56 Europe API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 57 Europe API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 58 Europe API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 59 Germany API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 60 Germany API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 61 Germany API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 62 Germany API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 63 Germany API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 64 Germany API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 65 U.K API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 66 U.K API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 67 U.K API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 68 U.K API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 69 U.K API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 70 U.K API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 71 U.K API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 72 Italy API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 73 Italy API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 74 Italy API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 75 Italy API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 76 Italy API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 77 Spain API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 78 Spain API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 79 Spain API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 80 Spain API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 81 Spain API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 82 Spain API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 83 France API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 84 France API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 85 France API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 86 France API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 87 France API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 88 France API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 89 Netherlands API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 90 Netherlands API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 91 Netherlands API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 92 Netherlands API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 93 Netherlands API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 94 Netherlands API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 95 Russia API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 96 Russia API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 97 Russia API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 98 Russia API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 99 Russia API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 100 Russia API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 101 Switzerland API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 102 Switzerland API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 103 Switzerland API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 104 Switzerland API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 105 Switzerland API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 106 Switzerland API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 107 Turkey API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 108 Turkey API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 109 Turkey API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 110 Turkey API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 111 Turkey API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 112 Turkey API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 113 Austria API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 114 Austria API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 115 Austria API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 116 Austria API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 117 Austria API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 118 Austria API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 119 Norway API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 120 Norway API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 121 Norway API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 122 Norway API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 123 Norway API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 124 Norway API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 125 Hungary API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 126 Hungary API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 127 Hungary API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 128 Hungary API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 129 Hungary API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 130 Hungary API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 131 Lithuania API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 132 Lithuania API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 133 Lithuania API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 134 Lithuania API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 135 Lithuania API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 136 Lithuania API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 137 Ireland API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 138 Ireland API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 139 Ireland API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 140 Ireland API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 141 Ireland API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 142 Ireland API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 143 Poland API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 144 Poland API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 145 Poland API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 146 Poland API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 147 Poland API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 148 Poland API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 149 Rest of Asia Pacific API intermediates market, By Type, 2019-2028 (USD Million)
Liste des figures
FIGURE 1 Europe API INTERMEDIATES MARKET: SEGMENTATION
FIGURE 2 EUROPE API INTERMEDIATES MARKET: DATA TRIANGULATION
FIGURE 3 Europe API intermediates Market: DROC ANALYSIS
FIGURE 4 Europe API intermediates market: Europe VS REGIONAL MARKET ANALYSIS
FIGURE 5 Europe API intermediates Market: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE API intermediates MARKET: MULTIVARIATE MODELLING
FIGURE 7 EUROPE API intermediates MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 EUROPE API INTERMEDIATES MARKET: DBMR MARKET POSITION GRID
FIGURE 9 EUROPE API INTERMEDIATES MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE API intermediates MARKET: MARKET type COVERAGE GRID
FIGURE 11 Europe API intermediates market: SEGMENTATION
FIGURE 12 Utilization of advanceD technology in active pharmaceutical ingredients (API) manufacturing is DRIVing THE Europe API intermediates MARKET IN THE FORECAST PERIOD OF 2021 to 2028
FIGURE 13 pharmaceutical / bulk drug intermediates SEGMENT is expected to account for the largest share of the Europe API INTERMEDIATES MARKET in 2021 & 2028
FIGURE 14 DRIVERS, RESTRAINTs, OPPORTUNITies AND CHALLENGEs OF Europe API Intermediates market
FIGURE 15 TOP 5 COUNTRIES FOR NUMBER OF PEOPLE AGED 20 TO 79 SUFFERING FROM DIABETES in 2019
FIGURE 16 ESTIMATED NUMBER OF DIFFERENT TYPEs OF CANCERS IN FEMALE POPULATION in 2020
FIGURE 17 ESTIMATED NUMBER OF DIFFERENT TYPEs OF CANCERS IN MALE POPULATION in 2020
FIGURE 18 EUROPE CAUSES OF DEATHs WITH THE CHRONIC DISEASES
FIGURE 19 NUMBER OF PERSON AGED 60 YEARS OR OVER BY REGIONS in 2020 (IN MILLIONS)
FIGURE 20 MARKET GROWTH IN CLINICAL CRO (IN USD MILLIONS)
FIGURE 21 Europe API intermediates market: BY type, 2021
FIGURE 22 Europe API intermediates market: BY type, 2019-2028 (USD Million)
FIGURE 23 Europe API intermediates market: BY type, CAGR (2021-2028)
FIGURE 24 Europe API intermediates market: BY type, LIFELINE CURVE
FIGURE 25 Europe API intermediates market: BY product, 2021
FIGURE 26 Europe API intermediates market: BY product, 2019-2028 (USD Million)
FIGURE 27 Europe API intermediates market: BY product, CAGR(2021-2028)
FIGURE 28 Europe API intermediates market: BY product, LIFELINE CURVE
FIGURE 29 Europe API intermediates market: BY therapeutic type, 2021
FIGURE 30 Europe API intermediates market: BY therapeutic type, 2019-2028 (USD Million)
FIGURE 31 Europe API intermediates market: BY therapeutic type, CAGR (2021-2028)
FIGURE 32 Europe API intermediates market: BY therapeutic type, LIFELINE CURVE
FIGURE 33 Europe API intermediates market: BY customers, 2021
FIGURE 34 Europe API intermediates market: BY customers, 2019-2028 (USD Million)
FIGURE 35 Europe API intermediates market: BY customers, CAGR (2021-2028)
FIGURE 36 Europe API intermediates market: BY customers, LIFELINE CURVE
FIGURE 37 Europe API intermediates market: BY end user, 2021
FIGURE 38 Europe API intermediates market: BY end user, 2019-2028 (USD Million)
FIGURE 39 Europe API intermediates market: BY end user, CAGR (2021-2028)
FIGURE 40 Europe API intermediates market: BY end user, LIFELINE CURVE
FIGURE 41 Europe API intermediates market: BY distribution channel, 2021
FIGURE 42 Europe API intermediates market: BY distribution channel, 2019-2028 (USD Million)
FIGURE 43 Europe API intermediates market: BY distribution channel, CAGR (2021-2028)
FIGURE 44 Europe API intermediates market: BY distribution channel, LIFELINE CURVE
FIGURE 45 Europe API Intermediates market: SNAPSHOT (2020)
FIGURE 46 Europe API INTERMEDIATEs market: BY COUNTRY (2020)
FIGURE 47 Europe API INTERMEDIATEs market: BY COUNTRY (2021 & 2028)
FIGURE 48 Europe API Intermediates market: BY COUNTRY (2020 & 2028)
FIGURE 49 Europe API Intermediates market: BY type (2021-2028)
FIGURE 50 Europe API Intermediates market: company share 2020 (%)
Méthodologie de recherche
La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.
La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.
Personnalisation disponible
Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.
